[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@WallStSai](/creator/twitter/WallStSai) "@MeadowCapital @BudwellGeorge @rhoman1996 When they have such great data in Ph2 for VK2809 why not go for Ph3 Do they lack confidence"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1948168835489542305) 2025-07-23 23:50:20 UTC 7069 followers, XXX engagements "@MeadowCapital @BudwellGeorge @rhoman1996 No more MASH for them as $MDGL is already excelling the space with their blockbuster drug Rezdiffra. Time for Viking to shred VK2809"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1948167602980659410) 2025-07-23 23:45:26 UTC 7074 followers, XXX engagements "$ISRG Earnings can have implications on $UNH as medical costs soar and MLR matters a lot to United Healthcare"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947710624114294801) 2025-07-22 17:29:34 UTC 7074 followers, XXX engagements "@bioinvestor24 $MTSR This is what I see today. XX strike puts may be added as hedge as big XX strike calls already have 5.5k as open interest"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945222407658037317) 2025-07-15 20:42:17 UTC 7066 followers, XXX engagements "$XBI Big Pharma will be looking for Commercial Stage companies which can generate billions in revenues. They have more demand as valuations are really compelling. $MDGL Madrigal is one of the best bet Big Pharma can make at this time which can generate $1B revenues by 2026"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947370669366214876) 2025-07-21 18:58:42 UTC 7071 followers, 1193 engagements "$XBI There is a very common misconception about M&A when a company announces new Credit Facility or Financing Deal Today $MDGL Madrigal Pharma announced they obtained $XXX Million credit facility from Blue Owl Capital in which $XXX Million is already funded and $XXX Million is available through 2027. Out of $XXX Million they paid off $XXX Million towards old Hercules Capital loan. So total left out is $XXX Million. Madrigal already has $XXX Million in cash. Madrigal may be trying to show strength that it can run independently probably to impress Big Pharma. But I dont think they are actively"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947824180805665225) 2025-07-23 01:00:48 UTC 7074 followers, 14.3K engagements "@JoseRestonVA Baker owns XX% stake in $MDGL"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944439210032718101) 2025-07-13 16:50:08 UTC 7068 followers, XXX engagements "$XBI TRUMP: WE WILL GIVE A YEAR YEAR AND A HALF TO COME IN ON PHARMA This is Big Positive right Is Trump confusing the street"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942632084972904769) 2025-07-08 17:09:16 UTC 7063 followers, 1585 engagements "@HarpA70278288 @PJamess69 May be get it down and announce a buyout strategy Same like $VRNA. Go see the chart and you will get it"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1948476416917733479) 2025-07-24 20:12:33 UTC 7074 followers, XX engagements "$MDGL Like said below Madrigal is very Undervalued Buyout discussions will obviously pick up pace now post Resmetirom patent extension news till 2044 ( This is huge ) I seriously budge on $BMY $PFE $MRK as strong contenders to acquire $MDGL"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945488675200016775) 2025-07-16 14:20:20 UTC 7068 followers, 1020 engagements "Over XX% had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment $LLY $NVO $VKTX $AMGN $XBI Glucagon-like peptide-1 receptor agonists (GLP-1RAs) drug-induced weight loss is associated with fat mass reduction but can also lead to nutritional deficiencies and loss of muscle Nutritional deficiencies were diagnosed in XXXX% of the patients within X months after GLP-1RA initiation and in XXXX% within XX months. Vitamin D deficiency was most common"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940003389758214440) 2025-07-01 11:03:46 UTC 7066 followers, 2543 engagements "Recent acquisitions of $BPMC ($9.5B) $VRNA ($10B) are clearly pointing $MDGL Madrigal could easily be the next M&A target for $XBI big pharma now as they rush to replace LOEs and bigger revenue holes. Madrigal may attract $12.5-$15 billion ( fully diluted shares ) in buyout premium according to current stock valuations Similar to Verona $VRNA its a single product company and obtained FDA approval for Rezdiffra in 2024. Company is currently working on MASH F4C trials. With EMA decision in August $MDGL Madrigal is expected to make $1-$1.2 billion net sales in 2026 $XBI $BMY $PFE $GILD #MASH"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942897275585401283) 2025-07-09 10:43:02 UTC 7068 followers, 3225 engagements "$BMY BRISTOL MYERS SQUIBB SAYS PHASE X INDEPENDENCE TRIAL FOR REBLOZYL DID NOT MEET ENDPOINT"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946174604965212315) 2025-07-18 11:45:58 UTC 7065 followers, 1535 engagements "$XBI US-SWISS TRADE DEAL LIKELY TO CONTAIN ASSURANCES ON PHARMACEUTICAL LEVY Huge Positive for Bios $XBI $NVO $NVS $RHHBY $MDGL"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1941157369091895605) 2025-07-04 15:29:16 UTC 7072 followers, 7394 engagements "$XBI Big Pharma Q2 earnings reports around the corner. Look for more M&A possibilities $GILD - 7/25 $MRK - 7/29 $AZN - 7/29 $BMY - 7/30 $ABBV - 7/31 $SNY - 7/31 $REGN - 8/1 $AMGN - 8/5 $PFE - 8/5 $NVO - 8/5 $LLY - 8/7 #biotech #mergersandacquistions"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946711214580470050) 2025-07-19 23:18:16 UTC 7068 followers, XXX engagements "$XBI $IBB Biotech Stocks Are Ready to Rebound $MRK $PFE $ABBV $BMY $GILD $SNY"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944707014426296407) 2025-07-14 10:34:17 UTC 7068 followers, 5649 engagements "@bioinvestor24 Big Pharma will look for candidates who can generate bigger revenues above $X billion as they have big LOE hole to fill especially $PFE $BMY $MRK"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947053475990274455) 2025-07-20 21:58:17 UTC 7069 followers, XXX engagements "$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946170474947375193) 2025-07-18 11:29:33 UTC 7074 followers, 8136 engagements "$BMY Bristol Myers badly needs big M&A soon to replace big LOEs revenues and I feel $MDGL is perfect fit for them $XBI I already explained why I think $BMY may acquire $MDGL below๐๐ผ"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943741676373033355) 2025-07-11 18:38:23 UTC 7069 followers, 3555 engagements "$NVS Novartis Q2 XX Core EPS: $XXXX (Est. $2.35) Net Sales: $XXXXX B (Est. $14.02B) Novartis raised its full-year core operating income forecast to low-teens growth citing strong Q2 drug sales $XBI #biotech"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945780282033844252) 2025-07-17 09:39:04 UTC 7068 followers, XXX engagements "$MDGL Interesting find with Madrigal Pharma Options Activity Player SOLD cumulative 1700 October17th XXX Calls over the course of time from March to May worth more than $X Million Same Player has been BUYING back those calls to close their position since last two days and I bet they will buy rest of XXX contracts back as well very soon Those options can be Covered Calls or Naked Options Selling ( I highly doubt ) This scenario is quite Bullish for the stock as player squares up his options Sell Call position Q2 Earnings and EMA Decision are looming in August and $MDGL has been a target of M&A"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946198123833090511) 2025-07-18 13:19:25 UTC 7065 followers, XXX engagements "$IBB Biotech ETF 8000 Calls bought for 11/21 expiration worth $X million $XBI What's brewing soon #biotech"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945666134692241646) 2025-07-17 02:05:29 UTC 7066 followers, 1524 engagements "$MDGL Two Big Catalysts (August) ๐ข Q2 Earnings - Exp Rev. $150M ๐ข EMA Decision"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942997941309874535) 2025-07-09 17:23:03 UTC 7068 followers, XXX engagements "$BMY $PFE Bristol-Myers Squibb and Pfizer will sell Eliquis directly to patients at a discounted cash price Eliquis has a list price of $XXX for a 30-day supply but will now offer a discounted cash price of $XXX a month"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945794304242258412) 2025-07-17 10:34:47 UTC 7068 followers, XXX engagements "@bioinvestor24 BP definitely have desperation on Obesity but I think at the same time $PFE $BMY $MRK wants Bigger revenues immediately as they lose Billions in LOEs soon. Recent Acq. $BPMC expected to make $XXX million and $VRNA expected to make $XXX million in annual sales for 2025"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947051774377922880) 2025-07-20 21:51:32 UTC 7069 followers, XXX engagements "$AZN ASTRAZENECA TO INVEST $XX BILLION IN UNITED STATES TO EXPAND MANUFACTURING RESEARCH"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947408610805362916) 2025-07-21 21:29:28 UTC 7072 followers, 2315 engagements "$MDGL Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra (Resmetirom) $XBI $PFE $BMY $GILD #MASH"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945455685220565089) 2025-07-16 12:09:14 UTC 7074 followers, 16.6K engagements "$CNC Centene is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance including the underlying guidance elements due to higher Medicaid costs $ELV $UNH $OSCR $CI $HUM $XLV"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940153255105110171) 2025-07-01 20:59:16 UTC 7066 followers, 5058 engagements "$MDGL Rezdiffra's market potential projecting the drug to achieve over $X billion in annual sales by 2026. Additionally the patent extends its market exclusivity up to 2044 presenting an opportunity worth $X billion in peak sales according to Piper Sandler"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945667433362051326) 2025-07-17 02:10:39 UTC 7069 followers, 1056 engagements "$BBIO Big Size 2400 July17th 2026 XX strike calls worth X million bought today $XBI Stock has been in M&A limelight lately"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1948046798397870354) 2025-07-23 15:45:24 UTC 7074 followers, XXX engagements "$BMY More Puts being added today. They should seriosuly get back to M&A deal making. Time is running out as LOE's loom and there is a good possibility of competetion for new commercial drugs $XBI"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946290249316847971) 2025-07-18 19:25:30 UTC 7072 followers, 1061 engagements "$XBI I like the last point - Pharma has big appetite for commercial stage companies Recent big commercial buyout deals $ITCI $BPMC $VRNA reflect the same fact. Next commercial stage company to get acquired is $MDGL possibly. Baker Bros back to deal making table @adamfeuerstein #Biotech"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942910643046154284) 2025-07-09 11:36:09 UTC 7068 followers, 1053 engagements "$VKTX Top XX Hedge Funds holding Viking Therapeutics stock $XBI #MergersAndAcquisitions"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944425661449302110) 2025-07-13 15:56:18 UTC 7068 followers, 11.3K engagements "$AKRO I think we should hear some updates this week regarding the @Street_Insider Akero buyout rumors back in May as the below July18th XXXX calls expire this week $XBI"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944833290650710230) 2025-07-14 18:56:04 UTC 7066 followers, XXX engagements "$XBI The pharmaceutical industry is facing some of its steepest patent cliffs to date. $MRK $PFE $BMY $AMGN $GILD $LLY $AZN $NVS $JNJ $SNY $ABBV Drugs worth about $180bn of revenue a year are going off patent in 2027 and 2028 according to research firm Evaluate Pharma representing almost XX per cent of the global market. Big Pharma is looking for biotechs with drugs that could come on to the market soon and sell in their billions. While patent cliffs are visible years ahead investors are often not that far sighted and can be surprised when they come says Tim Opler a managing director in"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944575606416715921) 2025-07-14 01:52:07 UTC 7066 followers, 1055 engagements "$MDGL Looks like Madrigal is following the footsteps of $VRNA buyout ๐ 1) First Raise Cash via Financing 2) Show Strength of Company 3) Attract Big Pharma 4) Get Bought Out Dont undermine Baker Brothers Mastermind"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1948108601601470695) 2025-07-23 19:50:59 UTC 7074 followers, 7720 engagements "$XBI $MDGL $AKRO $ETNB $VKTX New Study Projects Alarming Rise in MASLD Related Deaths by 2040 A recent U.S. study just published in JAMA Network Open has projected that deaths from Metabolic dysfunctionAssociated Steatotic Liver Disease (MASLD) will nearly double by 2040 climbing from XXXX to XXXX per 100000 persons. This follows a troubling rise in MASLD-related mortality between 2006 and 2023 with the sharpest increases seen in: Adults 65+ (projected rate more than doubling from XXXX to 7.12) Hispanic and non-Hispanic White populations Nonmetropolitan/rural areas Despite increased awareness"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944140953398259974) 2025-07-12 21:04:58 UTC 7068 followers, 9777 engagements "$NVO Results from a phase 1b/2a randomised controlled study: Amycretin a novel unimolecular GLP-1 and amylin receptor agonist administered subcutaneously A large number of participants withdrew from the study with a high proportion of discontinuations occurring due to reasons unrelated to treatment-emergent adverse events Source: $LLY $VKTX #GLP1 #weightloss"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1943661135447654459) 2025-07-11 13:18:20 UTC 7068 followers, 1334 engagements "$MDGL Q2 Earnings and EMA Approval are due mostly by Aug15th we never know we may see a deal by then. Also BP need to replace LOE as quick as possible and are already in hunt for commercial biotech companies. $MDGL is definitely a good match for BP as its peak revenues are expected to top $4-$5 billion. Buyout came come anytime I am with you"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944420131599176044) 2025-07-13 15:34:19 UTC 7068 followers, XXX engagements "$MDGL Top XX Hedge Funds account for XXXX million common stock thats almost XX% of total outstanding XXXX million shares of Madrigal Pharma $XBI #MergersAndAcquisitions"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944424205065347327) 2025-07-13 15:50:30 UTC 7066 followers, 1856 engagements "$MDGL Now Buyout will easily be on cards for Madrigal Pharma"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945455977781772464) 2025-07-16 12:10:24 UTC 7066 followers, 4384 engagements "$XBI Biotech Sector gonna squeeze tomorrow after positive $ABVX Phase X Results from both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer + More M&A ๐ฅ $PFE $MRK $BMY $JNJ $ABBV $SNY"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947809216258826726) 2025-07-23 00:01:20 UTC 7072 followers, 3408 engagements "GLP-1s High Discontinuation Rate $LLY $NVO $VKTX $XBI #GLP1"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1944933204051300601) 2025-07-15 01:33:05 UTC 7068 followers, 2647 engagements "$XBI Why Patents play a key role in successful biotech M&As A most recent example where patent played a key role in $JNJ s acquisition of $ITCI On Jan10th there was a PR from $ITCI that they reached patent litigation settlement with Sandoz. The agreement allows Sandoz to sell generic CAPLYTA starting July X 2040. Thats almost XX years from now. On Jan13th there was an official PR from $JNJ regarding $ITCI takeover for $XXXX Billion It just took two non-business days to reach an M&A deal post patent settlement news. The only hiccup for $JNJ to proceed on the buyout deal was $ITCI patent $MDGL"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947428838943953259) 2025-07-21 22:49:51 UTC 7074 followers, XXX engagements "$AKRO Are we still buying this Akero buyout rumor Stock is up XX% on just this rumor from SI. But at the same time Short Interest in Akero surged to all time highs. Very Interesting ๐คจ @Street_Insider $XBI $MDGL $ETNB"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946316125966368987) 2025-07-18 21:08:19 UTC 7069 followers, 1658 engagements "$PFE Pfizer Patents that Expire Soon Who will they buy to replace the Big revenue hole $XBI $VKTX $TGTX $BBIO $MDGL"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945301852293095510) 2025-07-16 01:57:58 UTC 7074 followers, 14.2K engagements "$XBI $BMY Bristol Myers Squibb faces big LOE as soon as 2026 Expiration of patents on BMS drugs could result in a $XX billion topline headwind to sales by 2030 Specifically analyst consensus revenue estimates as collected by Refinitv suggest that BMYs sales will likely drop to $XX billion by 2030 down from $XXXX billion in 2024. Bristol Myers Squibb faces the impending patent expiries of Eliquis Opdivo and Pomalyst. Both Eliquis and Pomalyst are due to lose their patent protection sometime around 2026 and Opdivo is likely to lose patent protection in 2028. Cumulatively these X products"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945317311545577622) 2025-07-16 02:59:23 UTC 7068 followers, 1711 engagements "$MRK MERCK WANTS TO EXPAND THROUGH BIGGER MERGERS AND ACQUISITIONS MIGHT GO BEYOND $XX BILLION $XBI #MergersAndAcquisitions"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942924492486951421) 2025-07-09 12:31:11 UTC 7074 followers, 14.7K engagements "BIG DAY for Health Insurers tomorrow with $ELV Elevance Health reporting Q2 earnings. Watch for knee jerk reactions in $CNC $UNH $HUM $CI $ELV The consensus EPS Estimate is $XXXX and the consensus Revenue Estimate is $48.2B Health Insurer stock sentiment is at all time low"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945678373285462157) 2025-07-17 02:54:07 UTC 7068 followers, 1204 engagements "$XBI Do we get any Biotech M&A for July4th long weekend Is the Big Pharma really ready to push the Buy button What are your most desirable or most probable candidates for acquisition #MergersAndAcquisitions $BMY $PFE $MRK $GILD $JNJ $NVS $SNY $REGN $AMGN $ABBV $ABT"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1940770406979531138) 2025-07-03 13:51:37 UTC 7066 followers, XXX engagements "$MDGL Citizens JMP analyst reiterated a Buy rating on Madrigal Pharmaceuticals today and set a price target of $XXX Most metrics in our 2Q25 physician survey improved from 1Q which is a good sign coming out of the typical 1Q reimbursement dynamics Our survey shows a higher prescribing rate greater proportion of patients on paid drug steady persistence and consistent long-term utilization expectations of50%. This could position $MDGL for another top-line beat with 2Q25 consensus at $159M representing XX% Q/ Q growth from $137M in 1Q25 while we are modeling $172M. We expect greater sales growth"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947629778183332281) 2025-07-22 12:08:18 UTC 7074 followers, 5808 engagements "$XBI I think @bioinvestor24 you just keep touting GLP-1s forever. I respect it but please try to increase your MASH knowledge as well. $MDGL Rezdiffra has multiple advantages - Fibrosis Reversal Lower Cholesterol and Weight Loss I have seen many patient feedbacks regarding losing good amount of weight with Rezdiffra and how effective the drug was treating their MASH condition and reversing Fibrosis. You always talk about high cost of the drug but you need to remember company has put in great efforts to get the first and only approved MASH drug into the market they didnt invent the drug"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942542053361041837) 2025-07-08 11:11:30 UTC 7068 followers, 2623 engagements "$VRNA There has been significant amount of insider selling just before Verona Pharma has been bought out by $MRK Merck on 7/9 $XBI There is a common misconception on social media - If insiders are selling company is not ready to sell. Technically there is no relationship between insiders selling and company being bought out. Most these insider sells are part of pre aggregated 10b5-1 trading plan adopted by Insiders. Rule 10b5-1 is a Securities and Exchange Commission (SEC) regulation that allows insiders of public companies to set up a trading plan for selling stocks they own. Rule 10b5-1"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947016218143068472) 2025-07-20 19:30:14 UTC 7074 followers, 6061 engagements "@yaireinhorn @Merck $BMY loses big from LOE and definitely need to look for big acquisitions now. Feel free to go through below post on my M&A prediction $BMY $MDGL"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947457824227004851) 2025-07-22 00:45:01 UTC 7069 followers, XXX engagements "$MDGL Madrigal Pharma's Valuation Current Market Cap: $XXX Billion Cash on Hand: $XXX Billion Enterprise Value: $XXX Billion FY'25 Sales: $XXX Million FY'26 Sales: $XXX Billion FY'30 Sales: $X Billion Stock Trading at 1x FY'30 Sales (EV) $XBI $BMY $PFE $MRK $GILD #BIOTECH"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1948482699104321652) 2025-07-24 20:37:31 UTC 7072 followers, XXX engagements "CHINESE BIOTECH SCIWIND BIOSCIENCES SHOWCASES CHALLENGER TO $LLY ELI LILLYS OBESITY DRUG Once approved Sciwinds ecnoglutide will compete with Novos Wegovy and Eli Lillys Zepbound as well as Innovent Biologics Inc in the China market $NVO $VKTX $XBI #GLP1"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1936933504345894921) 2025-06-22 23:45:08 UTC 7069 followers, 5167 engagements "$MDGL OPPENHEIMER RAISED ITS PRICE TARGET ON MADRIGAL PHARMACEUTICALS TO $500"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1945575594604822669) 2025-07-16 20:05:43 UTC 7066 followers, 5898 engagements "$ABBV AbbVie Unit Wins $XX Million from Revance Over Botox Patents Revance's anti-wrinkle medication Daxxify infringed patents covering Allergan's rival drug Botox"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947416196137017633) 2025-07-21 21:59:37 UTC 7066 followers, XXX engagements "@bioinvestor24 Do you think $MRK is still interested in $MLTX Its market cap is already $3.4B now"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947418959084397049) 2025-07-21 22:10:35 UTC 7067 followers, XXX engagements "$MDGL Rezdiffras peak revenues $4B. But stock trading only $6.3B which makes it very undervalued not even trading 2x peak sales. Madrigal would be a good strategic commercial stage fit for Big Pharma at this cheap valuation @semodough $XBI $BMY $PFE $GILD $AMGN $LLY"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1942913074287005819) 2025-07-09 11:45:49 UTC 7068 followers, 2581 engagements "@KNielsen2000 @bioinvestor24 @Street_Insider That really doesnt matter as there are many patient support options available now a days as they get to access drug for as low as $XX per month. So no big deal on pricing according to me"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1946323045078937603) 2025-07-18 21:35:49 UTC 7067 followers, XX engagements "@bradloncar Great Biotech Interviews Brad Really Appreciate it It would be great if you can get @MadrigalPharma $MDGL CEO on @BiotechTV Hope you book your next trip down to PA ๐"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947447327838638136) 2025-07-22 00:03:19 UTC 7068 followers, XXX engagements "$XBI That is why we are seeing more M&A deals this year in biotech space Big Pharma started acting swiftly on BD. We should see more bigger size deals as amount of revenue hole is big enough to fill for $PFE $BMY $MRK $AMGN $GILD $SNY $AZN $ABBV $LLY $JNJ"  [@WallStSai](/creator/x/WallStSai) on [X](/post/tweet/1947365521201995941) 2025-07-21 18:38:15 UTC 7070 followers, 11.2K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@WallStSai
"@MeadowCapital @BudwellGeorge @rhoman1996 When they have such great data in Ph2 for VK2809 why not go for Ph3 Do they lack confidence" @WallStSai on X 2025-07-23 23:50:20 UTC 7069 followers, XXX engagements
"@MeadowCapital @BudwellGeorge @rhoman1996 No more MASH for them as $MDGL is already excelling the space with their blockbuster drug Rezdiffra. Time for Viking to shred VK2809" @WallStSai on X 2025-07-23 23:45:26 UTC 7074 followers, XXX engagements
"$ISRG Earnings can have implications on $UNH as medical costs soar and MLR matters a lot to United Healthcare" @WallStSai on X 2025-07-22 17:29:34 UTC 7074 followers, XXX engagements
"@bioinvestor24 $MTSR This is what I see today. XX strike puts may be added as hedge as big XX strike calls already have 5.5k as open interest" @WallStSai on X 2025-07-15 20:42:17 UTC 7066 followers, XXX engagements
"$XBI Big Pharma will be looking for Commercial Stage companies which can generate billions in revenues. They have more demand as valuations are really compelling. $MDGL Madrigal is one of the best bet Big Pharma can make at this time which can generate $1B revenues by 2026" @WallStSai on X 2025-07-21 18:58:42 UTC 7071 followers, 1193 engagements
"$XBI There is a very common misconception about M&A when a company announces new Credit Facility or Financing Deal Today $MDGL Madrigal Pharma announced they obtained $XXX Million credit facility from Blue Owl Capital in which $XXX Million is already funded and $XXX Million is available through 2027. Out of $XXX Million they paid off $XXX Million towards old Hercules Capital loan. So total left out is $XXX Million. Madrigal already has $XXX Million in cash. Madrigal may be trying to show strength that it can run independently probably to impress Big Pharma. But I dont think they are actively" @WallStSai on X 2025-07-23 01:00:48 UTC 7074 followers, 14.3K engagements
"@JoseRestonVA Baker owns XX% stake in $MDGL" @WallStSai on X 2025-07-13 16:50:08 UTC 7068 followers, XXX engagements
"$XBI TRUMP: WE WILL GIVE A YEAR YEAR AND A HALF TO COME IN ON PHARMA This is Big Positive right Is Trump confusing the street" @WallStSai on X 2025-07-08 17:09:16 UTC 7063 followers, 1585 engagements
"@HarpA70278288 @PJamess69 May be get it down and announce a buyout strategy Same like $VRNA. Go see the chart and you will get it" @WallStSai on X 2025-07-24 20:12:33 UTC 7074 followers, XX engagements
"$MDGL Like said below Madrigal is very Undervalued Buyout discussions will obviously pick up pace now post Resmetirom patent extension news till 2044 ( This is huge ) I seriously budge on $BMY $PFE $MRK as strong contenders to acquire $MDGL" @WallStSai on X 2025-07-16 14:20:20 UTC 7068 followers, 1020 engagements
"Over XX% had nutritional deficiencies diagnosed within one-year of starting GLP-1RA treatment $LLY $NVO $VKTX $AMGN $XBI Glucagon-like peptide-1 receptor agonists (GLP-1RAs) drug-induced weight loss is associated with fat mass reduction but can also lead to nutritional deficiencies and loss of muscle Nutritional deficiencies were diagnosed in XXXX% of the patients within X months after GLP-1RA initiation and in XXXX% within XX months. Vitamin D deficiency was most common" @WallStSai on X 2025-07-01 11:03:46 UTC 7066 followers, 2543 engagements
"Recent acquisitions of $BPMC ($9.5B) $VRNA ($10B) are clearly pointing $MDGL Madrigal could easily be the next M&A target for $XBI big pharma now as they rush to replace LOEs and bigger revenue holes. Madrigal may attract $12.5-$15 billion ( fully diluted shares ) in buyout premium according to current stock valuations Similar to Verona $VRNA its a single product company and obtained FDA approval for Rezdiffra in 2024. Company is currently working on MASH F4C trials. With EMA decision in August $MDGL Madrigal is expected to make $1-$1.2 billion net sales in 2026 $XBI $BMY $PFE $GILD #MASH" @WallStSai on X 2025-07-09 10:43:02 UTC 7068 followers, 3225 engagements
"$BMY BRISTOL MYERS SQUIBB SAYS PHASE X INDEPENDENCE TRIAL FOR REBLOZYL DID NOT MEET ENDPOINT" @WallStSai on X 2025-07-18 11:45:58 UTC 7065 followers, 1535 engagements
"$XBI US-SWISS TRADE DEAL LIKELY TO CONTAIN ASSURANCES ON PHARMACEUTICAL LEVY Huge Positive for Bios $XBI $NVO $NVS $RHHBY $MDGL" @WallStSai on X 2025-07-04 15:29:16 UTC 7072 followers, 7394 engagements
"$XBI Big Pharma Q2 earnings reports around the corner. Look for more M&A possibilities $GILD - 7/25 $MRK - 7/29 $AZN - 7/29 $BMY - 7/30 $ABBV - 7/31 $SNY - 7/31 $REGN - 8/1 $AMGN - 8/5 $PFE - 8/5 $NVO - 8/5 $LLY - 8/7 #biotech #mergersandacquistions" @WallStSai on X 2025-07-19 23:18:16 UTC 7068 followers, XXX engagements
"$XBI $IBB Biotech Stocks Are Ready to Rebound $MRK $PFE $ABBV $BMY $GILD $SNY" @WallStSai on X 2025-07-14 10:34:17 UTC 7068 followers, 5649 engagements
"@bioinvestor24 Big Pharma will look for candidates who can generate bigger revenues above $X billion as they have big LOE hole to fill especially $PFE $BMY $MRK" @WallStSai on X 2025-07-20 21:58:17 UTC 7069 followers, XXX engagements
"$NVS Novartis CFO on M&A + Not prioritizing Share Buybacks over Bolt-On M&A + Looking at bigger Bolt-On Deals + Have excellent BD and M&A Team + Have $XX Billion Free Cash Flow $XBI $MDGL $BBIO $TGTX $CYTK" @WallStSai on X 2025-07-18 11:29:33 UTC 7074 followers, 8136 engagements
"$BMY Bristol Myers badly needs big M&A soon to replace big LOEs revenues and I feel $MDGL is perfect fit for them $XBI I already explained why I think $BMY may acquire $MDGL below๐๐ผ" @WallStSai on X 2025-07-11 18:38:23 UTC 7069 followers, 3555 engagements
"$NVS Novartis Q2 XX Core EPS: $XXXX (Est. $2.35) Net Sales: $XXXXX B (Est. $14.02B) Novartis raised its full-year core operating income forecast to low-teens growth citing strong Q2 drug sales $XBI #biotech" @WallStSai on X 2025-07-17 09:39:04 UTC 7068 followers, XXX engagements
"$MDGL Interesting find with Madrigal Pharma Options Activity Player SOLD cumulative 1700 October17th XXX Calls over the course of time from March to May worth more than $X Million Same Player has been BUYING back those calls to close their position since last two days and I bet they will buy rest of XXX contracts back as well very soon Those options can be Covered Calls or Naked Options Selling ( I highly doubt ) This scenario is quite Bullish for the stock as player squares up his options Sell Call position Q2 Earnings and EMA Decision are looming in August and $MDGL has been a target of M&A" @WallStSai on X 2025-07-18 13:19:25 UTC 7065 followers, XXX engagements
"$IBB Biotech ETF 8000 Calls bought for 11/21 expiration worth $X million $XBI What's brewing soon #biotech" @WallStSai on X 2025-07-17 02:05:29 UTC 7066 followers, 1524 engagements
"$MDGL Two Big Catalysts (August) ๐ข Q2 Earnings - Exp Rev. $150M ๐ข EMA Decision" @WallStSai on X 2025-07-09 17:23:03 UTC 7068 followers, XXX engagements
"$BMY $PFE Bristol-Myers Squibb and Pfizer will sell Eliquis directly to patients at a discounted cash price Eliquis has a list price of $XXX for a 30-day supply but will now offer a discounted cash price of $XXX a month" @WallStSai on X 2025-07-17 10:34:47 UTC 7068 followers, XXX engagements
"@bioinvestor24 BP definitely have desperation on Obesity but I think at the same time $PFE $BMY $MRK wants Bigger revenues immediately as they lose Billions in LOEs soon. Recent Acq. $BPMC expected to make $XXX million and $VRNA expected to make $XXX million in annual sales for 2025" @WallStSai on X 2025-07-20 21:51:32 UTC 7069 followers, XXX engagements
"$AZN ASTRAZENECA TO INVEST $XX BILLION IN UNITED STATES TO EXPAND MANUFACTURING RESEARCH" @WallStSai on X 2025-07-21 21:29:28 UTC 7072 followers, 2315 engagements
"$MDGL Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra (Resmetirom) $XBI $PFE $BMY $GILD #MASH" @WallStSai on X 2025-07-16 12:09:14 UTC 7074 followers, 16.6K engagements
"$CNC Centene is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance including the underlying guidance elements due to higher Medicaid costs $ELV $UNH $OSCR $CI $HUM $XLV" @WallStSai on X 2025-07-01 20:59:16 UTC 7066 followers, 5058 engagements
"$MDGL Rezdiffra's market potential projecting the drug to achieve over $X billion in annual sales by 2026. Additionally the patent extends its market exclusivity up to 2044 presenting an opportunity worth $X billion in peak sales according to Piper Sandler" @WallStSai on X 2025-07-17 02:10:39 UTC 7069 followers, 1056 engagements
"$BBIO Big Size 2400 July17th 2026 XX strike calls worth X million bought today $XBI Stock has been in M&A limelight lately" @WallStSai on X 2025-07-23 15:45:24 UTC 7074 followers, XXX engagements
"$BMY More Puts being added today. They should seriosuly get back to M&A deal making. Time is running out as LOE's loom and there is a good possibility of competetion for new commercial drugs $XBI" @WallStSai on X 2025-07-18 19:25:30 UTC 7072 followers, 1061 engagements
"$XBI I like the last point - Pharma has big appetite for commercial stage companies Recent big commercial buyout deals $ITCI $BPMC $VRNA reflect the same fact. Next commercial stage company to get acquired is $MDGL possibly. Baker Bros back to deal making table @adamfeuerstein #Biotech" @WallStSai on X 2025-07-09 11:36:09 UTC 7068 followers, 1053 engagements
"$VKTX Top XX Hedge Funds holding Viking Therapeutics stock $XBI #MergersAndAcquisitions" @WallStSai on X 2025-07-13 15:56:18 UTC 7068 followers, 11.3K engagements
"$AKRO I think we should hear some updates this week regarding the @Street_Insider Akero buyout rumors back in May as the below July18th XXXX calls expire this week $XBI" @WallStSai on X 2025-07-14 18:56:04 UTC 7066 followers, XXX engagements
"$XBI The pharmaceutical industry is facing some of its steepest patent cliffs to date. $MRK $PFE $BMY $AMGN $GILD $LLY $AZN $NVS $JNJ $SNY $ABBV Drugs worth about $180bn of revenue a year are going off patent in 2027 and 2028 according to research firm Evaluate Pharma representing almost XX per cent of the global market. Big Pharma is looking for biotechs with drugs that could come on to the market soon and sell in their billions. While patent cliffs are visible years ahead investors are often not that far sighted and can be surprised when they come says Tim Opler a managing director in" @WallStSai on X 2025-07-14 01:52:07 UTC 7066 followers, 1055 engagements
"$MDGL Looks like Madrigal is following the footsteps of $VRNA buyout ๐ 1) First Raise Cash via Financing 2) Show Strength of Company 3) Attract Big Pharma 4) Get Bought Out Dont undermine Baker Brothers Mastermind" @WallStSai on X 2025-07-23 19:50:59 UTC 7074 followers, 7720 engagements
"$XBI $MDGL $AKRO $ETNB $VKTX New Study Projects Alarming Rise in MASLD Related Deaths by 2040 A recent U.S. study just published in JAMA Network Open has projected that deaths from Metabolic dysfunctionAssociated Steatotic Liver Disease (MASLD) will nearly double by 2040 climbing from XXXX to XXXX per 100000 persons. This follows a troubling rise in MASLD-related mortality between 2006 and 2023 with the sharpest increases seen in: Adults 65+ (projected rate more than doubling from XXXX to 7.12) Hispanic and non-Hispanic White populations Nonmetropolitan/rural areas Despite increased awareness" @WallStSai on X 2025-07-12 21:04:58 UTC 7068 followers, 9777 engagements
"$NVO Results from a phase 1b/2a randomised controlled study: Amycretin a novel unimolecular GLP-1 and amylin receptor agonist administered subcutaneously A large number of participants withdrew from the study with a high proportion of discontinuations occurring due to reasons unrelated to treatment-emergent adverse events Source: $LLY $VKTX #GLP1 #weightloss" @WallStSai on X 2025-07-11 13:18:20 UTC 7068 followers, 1334 engagements
"$MDGL Q2 Earnings and EMA Approval are due mostly by Aug15th we never know we may see a deal by then. Also BP need to replace LOE as quick as possible and are already in hunt for commercial biotech companies. $MDGL is definitely a good match for BP as its peak revenues are expected to top $4-$5 billion. Buyout came come anytime I am with you" @WallStSai on X 2025-07-13 15:34:19 UTC 7068 followers, XXX engagements
"$MDGL Top XX Hedge Funds account for XXXX million common stock thats almost XX% of total outstanding XXXX million shares of Madrigal Pharma $XBI #MergersAndAcquisitions" @WallStSai on X 2025-07-13 15:50:30 UTC 7066 followers, 1856 engagements
"$MDGL Now Buyout will easily be on cards for Madrigal Pharma" @WallStSai on X 2025-07-16 12:10:24 UTC 7066 followers, 4384 engagements
"$XBI Biotech Sector gonna squeeze tomorrow after positive $ABVX Phase X Results from both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer + More M&A ๐ฅ $PFE $MRK $BMY $JNJ $ABBV $SNY" @WallStSai on X 2025-07-23 00:01:20 UTC 7072 followers, 3408 engagements
"GLP-1s High Discontinuation Rate $LLY $NVO $VKTX $XBI #GLP1" @WallStSai on X 2025-07-15 01:33:05 UTC 7068 followers, 2647 engagements
"$XBI Why Patents play a key role in successful biotech M&As A most recent example where patent played a key role in $JNJ s acquisition of $ITCI On Jan10th there was a PR from $ITCI that they reached patent litigation settlement with Sandoz. The agreement allows Sandoz to sell generic CAPLYTA starting July X 2040. Thats almost XX years from now. On Jan13th there was an official PR from $JNJ regarding $ITCI takeover for $XXXX Billion It just took two non-business days to reach an M&A deal post patent settlement news. The only hiccup for $JNJ to proceed on the buyout deal was $ITCI patent $MDGL" @WallStSai on X 2025-07-21 22:49:51 UTC 7074 followers, XXX engagements
"$AKRO Are we still buying this Akero buyout rumor Stock is up XX% on just this rumor from SI. But at the same time Short Interest in Akero surged to all time highs. Very Interesting ๐คจ @Street_Insider $XBI $MDGL $ETNB" @WallStSai on X 2025-07-18 21:08:19 UTC 7069 followers, 1658 engagements
"$PFE Pfizer Patents that Expire Soon Who will they buy to replace the Big revenue hole $XBI $VKTX $TGTX $BBIO $MDGL" @WallStSai on X 2025-07-16 01:57:58 UTC 7074 followers, 14.2K engagements
"$XBI $BMY Bristol Myers Squibb faces big LOE as soon as 2026 Expiration of patents on BMS drugs could result in a $XX billion topline headwind to sales by 2030 Specifically analyst consensus revenue estimates as collected by Refinitv suggest that BMYs sales will likely drop to $XX billion by 2030 down from $XXXX billion in 2024. Bristol Myers Squibb faces the impending patent expiries of Eliquis Opdivo and Pomalyst. Both Eliquis and Pomalyst are due to lose their patent protection sometime around 2026 and Opdivo is likely to lose patent protection in 2028. Cumulatively these X products" @WallStSai on X 2025-07-16 02:59:23 UTC 7068 followers, 1711 engagements
"$MRK MERCK WANTS TO EXPAND THROUGH BIGGER MERGERS AND ACQUISITIONS MIGHT GO BEYOND $XX BILLION $XBI #MergersAndAcquisitions" @WallStSai on X 2025-07-09 12:31:11 UTC 7074 followers, 14.7K engagements
"BIG DAY for Health Insurers tomorrow with $ELV Elevance Health reporting Q2 earnings. Watch for knee jerk reactions in $CNC $UNH $HUM $CI $ELV The consensus EPS Estimate is $XXXX and the consensus Revenue Estimate is $48.2B Health Insurer stock sentiment is at all time low" @WallStSai on X 2025-07-17 02:54:07 UTC 7068 followers, 1204 engagements
"$XBI Do we get any Biotech M&A for July4th long weekend Is the Big Pharma really ready to push the Buy button What are your most desirable or most probable candidates for acquisition #MergersAndAcquisitions $BMY $PFE $MRK $GILD $JNJ $NVS $SNY $REGN $AMGN $ABBV $ABT" @WallStSai on X 2025-07-03 13:51:37 UTC 7066 followers, XXX engagements
"$MDGL Citizens JMP analyst reiterated a Buy rating on Madrigal Pharmaceuticals today and set a price target of $XXX Most metrics in our 2Q25 physician survey improved from 1Q which is a good sign coming out of the typical 1Q reimbursement dynamics Our survey shows a higher prescribing rate greater proportion of patients on paid drug steady persistence and consistent long-term utilization expectations of50%. This could position $MDGL for another top-line beat with 2Q25 consensus at $159M representing XX% Q/ Q growth from $137M in 1Q25 while we are modeling $172M. We expect greater sales growth" @WallStSai on X 2025-07-22 12:08:18 UTC 7074 followers, 5808 engagements
"$XBI I think @bioinvestor24 you just keep touting GLP-1s forever. I respect it but please try to increase your MASH knowledge as well. $MDGL Rezdiffra has multiple advantages - Fibrosis Reversal Lower Cholesterol and Weight Loss I have seen many patient feedbacks regarding losing good amount of weight with Rezdiffra and how effective the drug was treating their MASH condition and reversing Fibrosis. You always talk about high cost of the drug but you need to remember company has put in great efforts to get the first and only approved MASH drug into the market they didnt invent the drug" @WallStSai on X 2025-07-08 11:11:30 UTC 7068 followers, 2623 engagements
"$VRNA There has been significant amount of insider selling just before Verona Pharma has been bought out by $MRK Merck on 7/9 $XBI There is a common misconception on social media - If insiders are selling company is not ready to sell. Technically there is no relationship between insiders selling and company being bought out. Most these insider sells are part of pre aggregated 10b5-1 trading plan adopted by Insiders. Rule 10b5-1 is a Securities and Exchange Commission (SEC) regulation that allows insiders of public companies to set up a trading plan for selling stocks they own. Rule 10b5-1" @WallStSai on X 2025-07-20 19:30:14 UTC 7074 followers, 6061 engagements
"@yaireinhorn @Merck $BMY loses big from LOE and definitely need to look for big acquisitions now. Feel free to go through below post on my M&A prediction $BMY $MDGL" @WallStSai on X 2025-07-22 00:45:01 UTC 7069 followers, XXX engagements
"$MDGL Madrigal Pharma's Valuation Current Market Cap: $XXX Billion Cash on Hand: $XXX Billion Enterprise Value: $XXX Billion FY'25 Sales: $XXX Million FY'26 Sales: $XXX Billion FY'30 Sales: $X Billion Stock Trading at 1x FY'30 Sales (EV) $XBI $BMY $PFE $MRK $GILD #BIOTECH" @WallStSai on X 2025-07-24 20:37:31 UTC 7072 followers, XXX engagements
"CHINESE BIOTECH SCIWIND BIOSCIENCES SHOWCASES CHALLENGER TO $LLY ELI LILLYS OBESITY DRUG Once approved Sciwinds ecnoglutide will compete with Novos Wegovy and Eli Lillys Zepbound as well as Innovent Biologics Inc in the China market $NVO $VKTX $XBI #GLP1" @WallStSai on X 2025-06-22 23:45:08 UTC 7069 followers, 5167 engagements
"$MDGL OPPENHEIMER RAISED ITS PRICE TARGET ON MADRIGAL PHARMACEUTICALS TO $500" @WallStSai on X 2025-07-16 20:05:43 UTC 7066 followers, 5898 engagements
"$ABBV AbbVie Unit Wins $XX Million from Revance Over Botox Patents Revance's anti-wrinkle medication Daxxify infringed patents covering Allergan's rival drug Botox" @WallStSai on X 2025-07-21 21:59:37 UTC 7066 followers, XXX engagements
"@bioinvestor24 Do you think $MRK is still interested in $MLTX Its market cap is already $3.4B now" @WallStSai on X 2025-07-21 22:10:35 UTC 7067 followers, XXX engagements
"$MDGL Rezdiffras peak revenues $4B. But stock trading only $6.3B which makes it very undervalued not even trading 2x peak sales. Madrigal would be a good strategic commercial stage fit for Big Pharma at this cheap valuation @semodough $XBI $BMY $PFE $GILD $AMGN $LLY" @WallStSai on X 2025-07-09 11:45:49 UTC 7068 followers, 2581 engagements
"@KNielsen2000 @bioinvestor24 @Street_Insider That really doesnt matter as there are many patient support options available now a days as they get to access drug for as low as $XX per month. So no big deal on pricing according to me" @WallStSai on X 2025-07-18 21:35:49 UTC 7067 followers, XX engagements
"@bradloncar Great Biotech Interviews Brad Really Appreciate it It would be great if you can get @MadrigalPharma $MDGL CEO on @BiotechTV Hope you book your next trip down to PA ๐" @WallStSai on X 2025-07-22 00:03:19 UTC 7068 followers, XXX engagements
"$XBI That is why we are seeing more M&A deals this year in biotech space Big Pharma started acting swiftly on BD. We should see more bigger size deals as amount of revenue hole is big enough to fill for $PFE $BMY $MRK $AMGN $GILD $SNY $AZN $ABBV $LLY $JNJ" @WallStSai on X 2025-07-21 18:38:15 UTC 7070 followers, 11.2K engagements
/creator/twitter::90807052/posts